200 related articles for article (PubMed ID: 31128028)
21. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
[TBL] [Abstract][Full Text] [Related]
22. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
[TBL] [Abstract][Full Text] [Related]
23. Overview of CD24 as a new molecular marker in ovarian cancer.
Tarhriz V; Bandehpour M; Dastmalchi S; Ouladsahebmadarek E; Zarredar H; Eyvazi S
J Cell Physiol; 2019 Mar; 234(3):2134-2142. PubMed ID: 30317611
[TBL] [Abstract][Full Text] [Related]
24. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.
Jiang J; Zhu Y; Wu C; Shen Y; Wei W; Chen L; Zheng X; Sun J; Lu B; Zhang X
Cancer Immunol Immunother; 2010 Nov; 59(11):1707-14. PubMed ID: 20725832
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
[TBL] [Abstract][Full Text] [Related]
26. B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.
Zhang X; Cai L; Zhang G; Shen Y; Huang J
Oncotarget; 2017 Mar; 8(12):18861-18871. PubMed ID: 28061481
[TBL] [Abstract][Full Text] [Related]
27. B7-H3 is related to tumor progression in ovarian cancer.
Zhang J; Liu L; Han S; Li Y; Qian Q; Zhang Q; Zhang H; Yang Z; Zhang Y
Oncol Rep; 2017 Oct; 38(4):2426-2434. PubMed ID: 28765941
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137
[TBL] [Abstract][Full Text] [Related]
29. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
Wu X; Zhang Z; Cai S
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
[TBL] [Abstract][Full Text] [Related]
30. B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.
Dong Q; Ma X
Biomed Res Int; 2015; 2015():156432. PubMed ID: 25954746
[TBL] [Abstract][Full Text] [Related]
31. B7-H4, a promising target for immunotherapy.
Wang JY; Wang WP
Cell Immunol; 2020 Jan; 347():104008. PubMed ID: 31733822
[TBL] [Abstract][Full Text] [Related]
32. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
33. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
[TBL] [Abstract][Full Text] [Related]
34. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
Kim NI; Park MH; Kweon SS; Lee JS
Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
[TBL] [Abstract][Full Text] [Related]
35. T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province.
Liang M; Li J; Wang D; Li S; Sun Y; Sun T; Zhang J; Chen X; Li Q; Sun S
Tumour Biol; 2014 Jan; 35(1):55-60. PubMed ID: 23873101
[TBL] [Abstract][Full Text] [Related]
36. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer.
Shi H; Ji M; Wu J; Zhou Q; Li X; Li Z; Zheng X; Xu B; Zhao W; Wu C; Jiang J
World J Surg Oncol; 2014 Jun; 12():188. PubMed ID: 24947047
[TBL] [Abstract][Full Text] [Related]
37. Roles of immune inhibitory molecule B7-H4 in cervical cancer.
Han S; Li Y; Zhang J; Liu L; Chen Q; Qian Q; Li S; Zhang Y
Oncol Rep; 2017 Apr; 37(4):2308-2316. PubMed ID: 28260085
[TBL] [Abstract][Full Text] [Related]
38. Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.
Wang P; Li C; Zhang F; Ma X; Gai X
Dis Markers; 2018; 2018():4310790. PubMed ID: 30363700
[TBL] [Abstract][Full Text] [Related]
39. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
40. Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
Smith JB; Lanitis E; Dangaj D; Buza E; Poussin M; Stashwick C; Scholler N; Powell DJ
Mol Ther; 2016 Nov; 24(11):1987-1999. PubMed ID: 27439899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
